Medical emergencies: Maths and methodology mix-up von Nederlof, P.

Volltext

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers von Lips, E H, Mulder, L, Oonk, A, van der Kolk, L E, Hogervorst, F B L, Imholz, A L T, Wesseling, J, Rodenhuis, S, Nederlof, P M

Volltext

The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs von van der Velden, D. L., Hoes, L. R., van der Wijngaart, H., van Berge Henegouwen, J. M., van Werkhoven, E., Roepman, P., Schilsky, R. L., de Leng, W. W. J., Huitema, A. D. R., Nuijen, B., Nederlof, P. M., van Herpen, C. M. L., de Groot, D. J. A., Devriese, L. A., Hoeben, A., de Jonge, M. J. A., Chalabi, M., Smit, E. F., de Langen, A. J., Mehra, N., Labots, M., Kapiteijn, E., Sleijfer, S., Cuppen, E., Verheul, H. M. W., Gelderblom, H., Voest, E. E.

Volltext

Molecular Tumor Boards: current practice and future needs von van der Velden, D.L., van Herpen, C.M.L., van Laarhoven, H.W.M., Smit, E.F., Groen, H.J.M., Willems, S.M., Nederlof, P.M., Langenberg, M.H.G., Cuppen, E., Sleijfer, S., Steeghs, N., Voest, E.E.

Volltext

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients von Vollebergh, M.A., Lips, E.H., Nederlof, P.M., Wessels, L.F.A., Schmidt, M.K., van Beers, E.H., Cornelissen, S., Holtkamp, M., Froklage, F.E., de Vries, E.G.E., Schrama, J.G., Wesseling, J., van de Vijver, M.J., van Tinteren, H., de Bruin, M., Hauptmann, M., Rodenhuis, S., Linn, S.C.

Volltext

A multiplex PCR predictor for aCGH success of FFPE samples von van Beers, E H, Joosse, S A, Ligtenberg, M J, Fles, R, Hogervorst, F B L, Verhoef, S, Nederlof, P M

Volltext

Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics von Lips, E. H., Mulder, L., de Ronde, J. J., Mandjes, I. A. M., Vincent, A., Vrancken Peeters, M. T. F. D., Nederlof, P. M., Wesseling, J., Rodenhuis, S.

Volltext

Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy von Lips, E.H., Mulder, L., Hannemann, J., Laddach, N., Vrancken Peeters, M.T.F.D., van de Vijver, M.J., Wesseling, J., Nederlof, P.M., Rodenhuis, S.

Volltext

EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer von van Zandwijk, N., Mathy, A., Boerrigter, L., Ruijter, H., Tielen, I., de Jong, D., Baas, P., Burgers, S., Nederlof, P.

Volltext

Goblet cell carcinoid of the appendix: a specific type of carcinoma von Van Eeden, S, Offerhaus, G J A, Hart, A A M, Boerrigter, L, Nederlof, P M, Porter, E, Van Velthuysen, M-L F

Volltext

Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach von Gille, J J P, Hogervorst, F B L, Pals, G, Wijnen, J Th, van Schooten, R J, Dommering, C J, Meijer, G A, Craanen, M E, Nederlof, P M, de Jong, D, McElgunn, C J, Schouten, J P, Menko, F H

Volltext

Comprehensive characterization of matched pre-treatment biopsies and residual disease of chemotherapy treated breast cancer von Hoogstraat, M, Lips, E, Mulder, L, Nederlof, P, Sonke, G, Rodenhuis, S, Wesseling, J, Wessels, L.F.A

Volltext

Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method von HOGERVORST, Frans B. L, NEDERLOF, Petra M, KLUIJT, Irma, DOMMERING, Charlotte, VERHOEF, Senno, SCHOUTEN, Jan P, VAN'T VEER, Laura J, PALS, Gerard, GILLE, Johan J. P, MCELGUNN, Cathal J, GRIPPELING, Maartje, PRUNTEL, Roelof, REGNERUS, Rein, VAN WELSEM, Tibor, VAN SPAENDONK, Resie, MENKO, Fred H

Volltext

A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients von Didraga, M. A., van Beers, E. H., Joosse, S. A., Brandwijk, K. I. M., Oldenburg, R. A., Wessels, L. F. A., Hogervorst, F. B. L., Ligtenberg, M. J., Hoogerbrugge, N., Verhoef, S., Devilee, P., Nederlof, P. M.

Volltext

Senescence bypass screen identifies TBX2 , which represses Cdkn2a ( p19 ARF ) and is amplified in a subset of human breast cancers von van Lohuizen, Maarten, Jacobs, Jacqueline J.L, Keblusek, Petra, Robanus-Maandag, Els, Kristel, Petra, Lingbeek, Merel, Nederlof, Petra M, van Welsem, Tibor, van de Vijver, Marc J, Koh, Eugene Y, Daley, George Q

Volltext

Differential Diagnosis of Pulmonary Carcinoma Following Head and Neck Cancer by Genetic Analysis von GEURTS, T. W, VAN VELTHUYSEN, M. L. F, BROEKMAN, F, HOOFT VAN HUYSDUYNEN, T, VAN DEN BREKEL, M. W. M, VAN ZANDWIJK, N, VAN TINTEREN, H, NEDERLOF, P, BALM, A. J. M, BRAKENHOFF, R. H

Volltext

Nuclear Localization Signals of Human and Thermoplasma Proteasomal α Subunits are Functional in vitro von Nederlof, P M, Wang, H R, Baumeister, W

Volltext

193P Adjuvant capecitabine-containing chemotherapy is effective in both BRCA1-like and non-BRCA1-like early-stage TNBC patients von de Boo, L., Jóźwiak, K., Joensuu, H., Lauttia, S., Opdam, M., van Steenis, C., Brugman, W., Kluin, R., Schouten, P., Kok, M., Nederlof, P., Hauptmann, M., Linn, S.

Volltext

A tumour with a neuroendocrine and papillary serous component: two or a pair? von van Eeden, S, Nederlof, P M, Taal, B G, Offerhaus, G J A, van Velthuysen, M-L F

Volltext

177 - Comprehensive characterization of matched pre-treatment biopsies and residual disease of chemotherapy treated breast cancer von Hoogstraat, M., Lips, E., Mulder, L., Nederlof, P., Sonke, G., Rodenhuis, S., Wesseling, J., Wessels, L.F.A.

Volltext